ArticleTheranostics2024

A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.

Zhiyong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.